Kate Farms Inc
5
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Role: lead
Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Months.
Role: lead
Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy
Role: collaborator
Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1
Role: lead
Partial-enteral Nutrition Protocol for Crohn's Disease
Role: lead
All 5 trials loaded